Cargando…

Development and clinical feasibility study of a brief version of an addiction‐focused phenotyping battery in females receiving buprenorphine for opioid use disorder

INTRODUCTION: We aimed to streamline the NIDA Phenotyping Assessment Battery (PhAB), a package of self‐report scales and neurobehavioral tasks used in substance use disorder (SUD) clinical trials, for clinical administration ease. Tailoring the PhAB to shorten administration time for a treatment set...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parlier‐Ahmad, Anna Beth, Eglovitch, Michelle, Legge, Catherine, Keyser‐Marcus, Lori A., Bjork, James M., Adams, Amanda, Ramey, Tanya, Moeller, Frederick Gerard, Martin, Caitlin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454248/ https://www.ncbi.nlm.nih.gov/pubmed/37367725 http://dx.doi.org/10.1002/brb3.3128

Ejemplares similares

Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder
por: Eglovitch, Michelle, et al.
Publicado: (2023)

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2021)

Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder
por: Radic, Maja, et al.
Publicado: (2022)

Project BETTER: A Family-Centered, Technology-Delivered Intervention for Pregnant People with Opioid Use Disorder
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2023)

Project BETTER: Preliminary Feasibility and Acceptability of a Technology-Delivered Educational Program for Pregnant and Postpartum People with Opioid Use Disorder
por: Martin, Sarah, et al.
Publicado: (2022)

Erratum to ‘Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder’ [Drug and Alcohol Dependence Reports 3 (2022) 100062]
por: Radic, Maja, et al.
Publicado: (2022)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Management of opioid addiction with buprenorphine: French history and current management
por: Poloméni, Pierre, et al.
Publicado: (2014)

Social Information Processing in Substance Use Disorders: Insights From an Emotional Go-Nogo Task
por: Bjork, James M., et al.
Publicado: (2021)

New developments in managing opioid addiction: impact of a subdermal buprenorphine implant
por: Itzoe, MariaLisa, et al.
Publicado: (2017)

Is Buprenorphine-Naloxone Ready for Prime Time in the Treatment of Opioid Addiction in Managed Care?
por: Curtiss, Frederic R.
Publicado: (2008)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Preliminary Findings of Weaker Executive Control Network Resting State fMRI Functional Connectivity in Opioid Use Disorder compared to Healthy Controls
por: Woisard, Kyle, et al.
Publicado: (2021)

Patient perspectives on depot buprenorphine treatment for opioid addiction – a qualitative interview study
por: Johnson, Björn, et al.
Publicado: (2022)

Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2021)

Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood
por: Leventelis, Christonikos, et al.
Publicado: (2019)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)
por: Khatri, Utsha G., et al.
Publicado: (2022)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Chronic Pelvic Pain and Sexual Dysfunction Among Females and Males Receiving Treatment for Opioid Use Disorder
por: Reichmann, Geetika, et al.
Publicado: (2022)

Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
por: Elman, Igor, et al.
Publicado: (2020)

Sex Specific Sleep Parameters Among People With Substance Use Disorder
por: Martin, Caitlin E., et al.
Publicado: (2022)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders
por: Houghton, David C., et al.
Publicado: (2023)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
por: Tobacyk, Julia, et al.
Publicado: (2023)

Author Correction: Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
por: Elman, Igor, et al.
Publicado: (2020)

Treatment of opioid dependence with buprenorphine: current update
por: Soyka, Michael
Publicado: (2017)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy
por: Pajusco, Benedetta, et al.
Publicado: (2012)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

What Recovery Means to Postpartum Women in Treatment for Opioid Use Disorder
por: Shadowen, Caroline, et al.
Publicado: (2022)

Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio
por: Molfenter, Todd, et al.
Publicado: (2015)

Pattern of buprenorphine abuse among opioid abusers in Nepal
por: Aich, Tapas Kumar, et al.
Publicado: (2010)

Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Opioid-Dependents
por: Ziaaddini, Hassan, et al.
Publicado: (2012)

Sleep problems in opioid dependent patients maintained on buprenorphine
por: Tripathi, R., et al.
Publicado: (2021)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_31ebtbui4bj7vt664j7q3vj00k